Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

UDG healthcare PLC 38.5a

18th May 2021 15:46

RNS Number : 0417Z
JPMorgan Securities Plc
18 May 2021
 

Ap24

 

AMENDMENT

 

FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

J.P. Morgan Securities Plc

Company dealt in

UDG Healthcare Plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

€0.05 Ordinary shares

Date of dealing

12 May 2021

 

2. DEALINGS (Note 2)

 

(a) Purchases and sales

 

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid

(Note 3)

3,989,827

10.3900 GBP

10.1500 GBP

 

 

Total number of securities disposed

Highest price received (Note 3)

Lowest price received

(Note 3)

16,204

 

1,568,164

N/A

 

10.3600 GBP

N/A

 

10.1500 GBP

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit

(Note 3)

Equity Swaps

Decrease Long

 

 

 

 

 

 

 

 

 

 

 

 

 

Decrease Short

 

 

 

 

 

 

 

 

 

 

 

 

Increase Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase Short

 

 

 

 

 

 

 

 

 

 

 

 

Opening a long position

 

Opening a short position

20,292

 3,174

 5,386

 3,278

 1,975

 993

 21

 7,335

 8,577

 1,207

 6,544

 218

 54

 

 38,830

 4,200

 10

 828

 18,154

 550

 38,830

 6,200

 2,951

 516

 880

 9,634

 

 19

 61

 1,511

 5,001

 369

 1,951

 619

 10,445

 649

 358

 419

 11,664

 2,217

 8,045

 195

 5,302

 791

 868

 109

 225

 

 210

 25,000

 198,816

 400

 100,000

 46

 40

 245,954

 14,676

 20,000

 28,511

 5,854

 

 261

 

 3,726

 955,029

 157,191

 45,000

 16,500

 40,000

 322,909

 17,629

 350,000

 21,980

 350,000

 31,000

 956,900

 3,986

 20,000

 1,129

 112,500

 75,000

 33,000

 16,500

10.16 GBP

10.1605 GBP

10.1831 GBP

10.1843 GBP

10.1855 GBP

10.1878 GBP

10.19 GBP

10.207 GBP

10.2072 GBP

10.2125 GBP

10.223 GBP

10.2301 GBP

10.2406 GBP

10.1639 GBP

10.1698 GBP

10.17 GBP

10.1857 GBP

10.2123 GBP

10.2152 GBP

10.2538 GBP

10.2591 GBP

10.2848 GBP

10.2998 GBP

10.3127 GBP

10.3201 GBP

10.16 GBP

10.1636 GBP

10.17 GBP

10.1787 GBP

10.1794 GBP

10.18 GBP

10.1805 GBP

10.1896 GBP

10.2031 GBP

10.2095 GBP

10.2097 GBP

10.2102 GBP

10.2103 GBP

10.2104 GBP

10.2447 GBP

10.2502 GBP

10.2507 GBP

10.2668 GBP

10.2899 GBP

10.2994 GBP

10.16 GBP

10.1602 GBP

10.1699 GBP

10.17 GBP

10.1752 GBP

10.1765 GBP

10.1813 GBP

10.1815 GBP

10.1993 GBP

10.2211 GBP

10.2344 GBP

10.2918 GBP

10.185 GBP

10.1551 GBP

10.1662 GBP

10.1676 GBP

10.1684 GBP

10.1701 GBP

10.1721 GBP

10.1726 GBP

10.1751 GBP

10.1771 GBP

10.1801 GBP

10.1804 GBP

10.1821 GBP

10.1899 GBP

10.191 GBP

10.1934 GBP

10.1952 GBP

10.2205 GBP

10.2259 GBP

10.3052 GBP

10.3152 GBP

 

Ap25

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)

 

 

 

 

 

3.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities 

under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. 

If none, this should be stated.

 

 

 

 

 

 

Date of disclosure

18 May 2021

Contact name

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

UDG Healthcare Plc

Nature of connection (Note 6)

Financial adviser to CD&R Fund XI

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEAPMITMTIBBJB

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00